Insider Transactions in Q3 2023 at Cv Rx, Inc. (CVRX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Jared Oasheim CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,862
+15.31%
|
$11,724
$2.1 P/Share
|
|
Sep 15
2023
|
Johnson & Johnson Innovation Jjdc, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,495,575
-100.0%
|
-
|
|
Aug 03
2023
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Open market or private sale
|
Direct |
628
-100.0%
|
$11,304
$18.55 P/Share
|
|
Aug 02
2023
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Bona fide gift
|
Direct |
2,000
-76.1%
|
-
|
|
Jul 31
2023
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
SELL
Open market or private sale
|
Direct |
1,122
-29.92%
|
$19,074
$17.49 P/Share
|
|
Jul 31
2023
|
Paul Verrastro CHIEF MKTG & STRAT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+50.0%
|
$18,750
$5.14 P/Share
|